Salute e Benessere

Rigid Endoscopes Market worth $2.32 billion by 2030 with 4.9% CAGR |…

Browse in-depth TOC on "Rigid Endoscopes Market" Browse in-depth TOC on "Rigid Endoscopes Market" 450 - Tables 60 - Figures 450 - Pages By type,the rigid endoscopes market is segmented into laparoscope, urology endoscopes, gynecology endoscopes, arthroscopes, cytoscopes, neuroendoscopes, and other rigid endoscopes. Among these, the laparoscopes segment accounted for the largest market share in 2024, owing to its broad clinical utility across both diagnostic and surgical...
PR Newswire
20/10/2025

Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell…

One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy in 16 patients with metastatic uveal melanoma in the ongoing Phase 1b trial continues to show strong clinical benefit with more mature data: cORR of 67%, mDOR of 11.0 months, mPFS of 8.5 months and mOS not reached at 14.3 months mFU Anzu-cel maintains a favorable tolerability profile in metastatic uveal melanoma Anti-tumor activity observed across metastases throughout the body, including liver lesions, and...
Nasdaq GlobeNewswire
20/10/2025

Compounding Pharmacy Market worth $19.41 billion by 2030 with 5.7% CAGR |…

Browse in-depth TOC on "Compounding Pharmacy Market" Browse in-depth TOC on "Compounding Pharmacy Market" 480 - Tables 60 - Figures 350 - Pages By product,the global compounding pharmacy market is divided into seven main categories based on product type: topical drugs, oral drugs, parenteral drugs, rec tal drugs, nasal drugs, ophthalmic drugs, and other products. The oral drugs segment holds the largest share in the market, driven by the demand for customized,...
PR Newswire
20/10/2025

Hyperhidrosis Treatment Market is expected to generate a revenue of USD 2.28…

For a detailed analysis of industry trends and growth drivers, explore the full Hyperhidrosis Treatment Market. For a detailed analysis of industry trends and growth drivers, explore the full Hyperhidrosis Treatment Market. Browse in-depth TOC 202 - Pages 126 – Tables 37 – Figures Global Hyperhidrosis Treatment Market Overview Market Driver 1. Rising Awareness and Diagnosis Rates of HyperhidrosisIncreasing awareness about hyperhidrosis as a genuine...
PR Newswire
20/10/2025

KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era…

The surgery was conducted on a 68-year-old man experiencing severe headaches and loss of concentration and involved removing a 4.5-centimeter brain tumor using robotic arms. The patient was discharged fully conscious within 24 hours, a recovery time nearly four times faster than traditional brain surgeries.Hospital officials credited the robotic tumor resection with minimizing surgical trauma and accelerating recovery. According to Dr. Homoud Aldahash, Consultant of Skull Base Tumors at...
Nasdaq GlobeNewswire
20/10/2025

Bone Regeneration Market to Reach $6.0 Billion by 2027 in the short term and…

Market Introduction Market Introduction The bone regeneration market refers to the segment of the medical industry focused on restoring or replacing damaged bone tissue through biological substitutes and advanced therapeutic techniques. This market encompasses bone grafts, bone graft substitutes, and regenerative materials, which are widely used in orthopedic surgeries, dental procedures, and trauma cases. Significant developments have shaped the market, such as the increasing adoption of...
PR Newswire
20/10/2025

Patient Safety and Risk Software Market worth $2.99 billion by 2030 with 11.3%…

Browse in-depth TOC on "Patient Safety and Risk Management Solutions Market" Browse in-depth TOC on "Patient Safety and Risk Management Solutions Market" 68 - Tables 60 - Figures 350 - Pages By function,Risk & safety management solutions hold the largest share due to their central role in incident reporting, adverse event tracking, and proactive risk mitigation for hospitals and healthcare systems. These platforms are widely adopted as they address the most critical...
PR Newswire
20/10/2025

MAXIMA GRUPĖ's Audit Comittee Elected for a New Term

On October 20, 2025, UAB “Vilniaus prekyba“, the sole shareholder of MAXIMA GRUPĖ, UAB (hereinafter - MAXIMA GRUPĖ), elected the MAXIMA GRUPĖ audit committee for a new four-year term. The term of office of MAXIMA GRUPĖ’s Audit Committee, comprising Chairwoman Irena Petruškevičienė, Eglė Čiužaitė, and Matas Kasperavičius was due to expire in March 2026, at the end of their four-year term, before the completion of the audit of MAXIMA GRUPĖ‘s 2025 financial statements.In order to ensure the...
Nasdaq GlobeNewswire
20/10/2025

New NYC 'Liver ICU' Lab Transforming Liver Disease Treatments

Quin Wills, CEO and Founder of Ochre, said: "Every year, 1.5 million people die of chronic liver disease. The only true cure today is a transplant. But with only about 40,000 done globally, liver medicine has become a medical lottery — not healthcare. Quin Wills, CEO and Founder of Ochre, said:"Every year, 1.5 million people die of chronic liver disease. The only true cure today is a transplant. But with only about 40,000 done globally, liver medicine has become a medical lottery —…
PR Newswire
20/10/2025

TUMI INVITES YOU TO "GIFT JOY" THIS HOLIDAY SEASON

As TUMI concludes its milestone 50th-anniversary year, the brand celebrates its legacy through a striking palette of Black and TUMI Red—its signature Pantone, an enduring symbol of strength and purpose. Featured across some of the brand's most iconic pieces within the Alpha, Alpha Bravo, Voyageur, and 19 Degree Aluminum collections, these colors celebrate TUMI's heritage while signaling its continued evolution: bold, resilient, and built for the journey ahead. As TUMI concludes its milestone...
PR Newswire
20/10/2025

Zero Candida Achieves Design Freeze and Begins Prototype Production of ZC-001…

"Achieving design freeze and starting prototype production marks a major advancement for Zero Candida as we move closer to delivering a much needed solution for women suffering from VVC," said Eli Ben-Haroosh, CEO of Zero Candida Technologies. "I want to thank our engineering team for their dedication in reaching this milestone and our Clinical Advisory Board for the valuable insights we've gained throughout the process." "Achieving design freeze and starting prototype…
PR Newswire
20/10/2025

Endo Launches First and Only Generic Version of RAVICTI® (glycerol…

"This first-to-market launch of generic RAVICTI® oral liquid is a meaningful milestone for Endo and important for our Generics business as we near the planned spin-off of Par Health," said Scott Sims, Senior Vice President and General Manager, Endo Injectable Solutions and Generics. "It expands access for patients and providers, and reinforces our commitment to quality, reliability, and leadership in complex generics." "This first-to-market launch of generic RAVICTI…
PR Newswire
20/10/2025

Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage…

Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program If approved, Tzield would be the first disease-modifying therapy to delay the progression of stage 3 T1D in adults and pediatric patients eight years of age and older recently diagnosed with stage 3 T1DTzield is also being reviewed under the accelerated approval programParis,October 20,2025.The US Food and Drug...
Nasdaq GlobeNewswire
20/10/2025

Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*)…

OASIS 4 trial highlights include: OASIS 4 trial highlights include: Investigating improvements in blood sugar and cardiovascular risk factorsIn an OASIS 4 post hoc analysis, investigators explored improvements in glycemic parameters and cardiovascular risk factors for people with obesity or overweight treated with once-daily oral semaglutide 25 mg. 1 Examining the efficacy of semaglutide across formulations (pill and injectable) in women's healthAdditional post hoc analyses from...
PR Newswire
20/10/2025

Taiwan Showcases Evidence-Based TCM at CPHI Frankfurt 2025

A central focus is the series of national TCM innovations developed by the National Research Institute of Chinese Medicine (NRICM): NRICM101 and NRICM102 for COVID-19, NRICM201 for dementia, and NRICM301 for post-stroke recovery. Among these, only NRICM101 and NRICM102 have reached the market, widely recognized during the pandemic as exemplar of evidence-based TCM. A central focus is the series of national TCM innovations developed by theNational Research Institute of Chinese Medicine (NRICM)...
PR Newswire
20/10/2025

A blueprint for Digital Health Medical Technologies (DHMTs)

OutspokenPR
20/10/2025

BTL's EMSCULPT NEO Used in Astronaut Training in Hungary for International Space…

"Studies show astronauts lose up to 30% of muscle mass in orbit, depending on the duration of the mission. EMSCULPT NEO has been an essential part of physical conditioning and rehabilitation, helping us maximize both muscle performance and recovery,"said Dr. Nóra Sydó, a cardiologist and sports medicine specialist from Semmelweis University,Budapest, who led the astronaut training team. EMSCULPT NEO was part of a comprehensive conditioning protocol designed to improve endurance,...
PR Newswire
20/10/2025

Faucet Market Growing at 5.93% CAGR to USD 31Bn by 2030, Amid Rising Smart…

Rising Focus on Water-Efficient Standards Rising Focus on Water-Efficient Standards Governments are tightening water-efficiency norms, pushing faucet makers to innovate and meet new certification standards. Eco-labels and rebate programs are shaping consumer preferences, turning compliance efforts into a market advantage for sustainable brands. Rising Urban Housing Upgrades Rapid urban growth in developing regions is driving steady demand for modern plumbing and stylish faucet...
PR Newswire
20/10/2025

Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating…

ATG-022 and CLINCH Study Overview ATG-022 and CLINCH Study Overview Key Results Presented Conclusions and Outlook Forward-looking statementsPlease refer:https://www.antengene.com/newsinfo/442 For more information, please contact: Investor Contacts:Donald LungE-mail:[email protected] BD Contacts:Ariel GuoE-mail:[email protected] Logo -https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg View original content:...
PR Newswire
20/10/2025

Sobi Q3 2025 report: Accelerated growth and portfolio momentum

Outlook 2025 - updated Outlook 2025 - updated Financial summary * The strategic portfolio includes Sobi's medicines Altuvoct, Aspaveli/Empaveli, Doptelet, Gamifant, Vonjo and Zynlonta, and royalty on Sanofi's sales of Altuviiio and Beyfortus. Investors, analysts, and the media are invited to a conference call on the same day at13:00 CEST,12:00 BST, and07:00 EDT. The call will include a presentation of the results and a Q&A session. The presentation can be followed...
PR Newswire
20/10/2025

Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on…

Tuesday, 4 November 2025 at 11:00 - 12:00am CETIn connection with the publication of Coloplast’s interim financial results for FY 2024/25, to be released same day around 07.00am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call. The webcast of the conference call will be available during and after the...
Nasdaq GlobeNewswire
20/10/2025

ESMO releases first-ever guidance for safe use of AI Language Models in cancer…

"Innovation must serve oncologists and, ultimately, patients, not confuse or mislead them," said Fabrice André, ESMO President. "With ELCAP, we offer a practical guide for using AI responsibly in oncology, one that protects data, ensures clinical oversight, and supports informed decision-making." "Innovation must serve oncologists and, ultimately, patients, not confuse or mislead them," said Fabrice André, ESMO President. "With ELCAP, we offer a practical guide…
PR Newswire
20/10/2025

Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing…

In parallel, Hengrui scheduled a series of academic events, fostering in-depth dialogue with leading global experts and clinical researchers on cutting-edge topics in oncology. These initiatives established a dynamic platform for international academic exchange and infused Chinese innovation into the global landscape of cancer diagnosis and treatment – marking a new chapter in Hengrui's journey of international scientific engagement. In parallel, Hengrui scheduled a series of academic events,...
PR Newswire
20/10/2025

Outfit7: Teeth and Treats Take Over My Talking Tom Friends in Halloween Update

Halloween Everywhere Halloween Everywhere From the moment players enter the game, the Halloween spirit is everywhere. Neighborhoods and character homes are festively decorated, complete with subtle spooky touches in every room. The fridge is stocked with seasonal favorites like "Witch Hat Pancakes" and "Zombie Sandwiches," while six special Halloween outfits - Werewolf, Mummy, Vampire, Pumpkin, Alien, and Bruja - add extra frightful flair (three of them even come with special…
PR Newswire
20/10/2025
Altri  Comunicati